Thymopentin as adjuvant in non-responders or hyporesponders to hepatitis B vaccination

scientific article published in November 1983

Thymopentin as adjuvant in non-responders or hyporesponders to hepatitis B vaccination is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0140-6736(83)91284-9
P8608Fatcat IDrelease_7wbltghxxvf5lbkpbuemavc2ia
P698PubMed publication ID6139582

P2093author name stringP J Grob
K Záruba
K Bolla
H Joller-Jemelka
M Rastorfer
P2860cites workHost defenses and immunologic alterations associated with chronic hemodialysisQ40293998
Immunogenicity of a hepatitis B subunit vaccine in hemodialysis and in renal transplant recipientsQ44566626
Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units: II, Haemodialysis patientsQ45056163
Phase variation in the modulation of the human immune responseQ85699245
P433issue8361
P407language of work or nameEnglishQ1860
P304page(s)1245
P577publication date1983-11-01
P1433published inThe LancetQ939416
P1476titleThymopentin as adjuvant in non-responders or hyporesponders to hepatitis B vaccination
P478volume2

Reverse relations

cites work (P2860)
Q41251653Nonresponse to hepatitis B vaccines and the kinetics of anti-HBs production
Q87461608Potential interventions for novel coronavirus in China: A systematic review

Search more.